Hamilton Lane Advisors LLC Recursion Pharmaceuticals, Inc. Transaction History

Hamilton Lane Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jun 03, 2024	BUY	$4.56 - $9.94 $439,921 - $958,951	96,474 New	96,474 $720,000
Q1 2023 May 28, 2024	BUY	$6.42 - $9.64 $619,363 - $930,009	96,474 New	96,474 $643,000
Q4 2022 Feb 09, 2023	BUY	$7.16 - $12.7 $290,867 - $515,924	40,624 Added 72.74%	96,474 $744,000
Q3 2022 Nov 08, 2022	BUY	$7.83 - $13.6 $318,093 - $552,500	40,625 Added 266.83%	55,850 $594,000
Q1 2022 May 04, 2022	SELL	$6.16 - $18.03 $73,291 - $214,520	-11,898 Reduced 43.87%	15,225 $109,000
Q4 2021 Jan 28, 2022	BUY	$16.14 - $21.86 $437,765 - $592,908	27,123 New	27,123 $465,000

286

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.38B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Hamilton Lane Advisors LLC with notifications on news.